Marc H. Hedrick M.D.
Net Worth

Last updated:

What is Marc H. Hedrick M.D. net worth?

The estimated net worth of Dr. Marc H. Hedrick M.D. is at least $18,455,926 as of 8 May 2024. He owns shares worth $6,413 as insider, has earned $4,053 from insider trading and has received compensation worth at least $18,445,460 in Plus Therapeutics, Inc..

What is the salary of Marc H. Hedrick M.D.?

Dr. Marc H. Hedrick M.D. salary is $838,430 per year as Pres, Chief Executive Officer & Director in Plus Therapeutics, Inc..

How old is Marc H. Hedrick M.D.?

Dr. Marc H. Hedrick M.D. is 62 years old, born in 1963.

What stocks does Marc H. Hedrick M.D. currently own?

As insider, Dr. Marc H. Hedrick M.D. owns shares in one company:

Company Title Shares Price per share Total value
Plus Therapeutics, Inc. (PSTV) Pres, Chief Executive Officer & Director 12,425 $0.52 $6,413

What does Plus Therapeutics, Inc. do?

Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium-186 NanoLiposome, a patented radiotherapy that targets central nervous system cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. It has a license agreement with NanoTx, Corp. to develop and commercialize NanoTx's glioblastoma treatment. The company was formerly known as Cytori Therapeutics, Inc. and changed its name to Plus Therapeutics, Inc. in July 2019. Plus Therapeutics, Inc. was founded in 1996 and is headquartered in Austin, Texas.

PSTV logo
PSTV
Plus Therapeutics, Inc.
$0.52

Marc H. Hedrick M.D. insider trading

Plus Therapeutics, Inc.

Dr. Marc H. Hedrick M.D. has made 2 insider trades between 2003-2024, according to the Form 4 filled with the SEC. Most recently he purchased 12,255 units of PSTV stock worth $25,000 on 8 May 2024.

The largest trade he's ever made was exercising 35,000 units of PSTV stock on 7 May 2009. As of 8 May 2024 he still owns at least 12,425 units of PSTV stock.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 12,255 $2.04 $25,000
Sale
Common Stock 2,068 $1.96 $4,053
Purchase
Common Stock 5,000 $0.65 $3,240
Purchase
Common Stock 5,000 $0.69 $3,450
Purchase
Common Stock 2,500 $0.68 $1,710
Purchase
Common Stock 2,500 $1.66 $4,150
Purchase
Common Stock 2,183 $2.28 $4,971
Purchase
Common Stock 2,500 N/A N/A
Purchase
Common Stock 2,500 $1.99 $4,975
Purchase
Common Stock 2,200 N/A N/A
Purchase
Common Stock 4,000 N/A N/A
Purchase
Common Stock 5,000 N/A N/A
Purchase
Common Stock 1,200 N/A N/A
Purchase
Common Stock 10,000 N/A N/A
Purchase
Common Stock 10,000 N/A N/A
Purchase
Common Stock 10,000 N/A N/A
Purchase
Common Stock 10,000 N/A N/A
Purchase
Common Stock 20,000 N/A N/A
Purchase
Common Stock 6,000 N/A N/A
Purchase
Common Stock 2,500 N/A N/A
Purchase
Warrant to Purchase Common Stock 35,000 N/A N/A
Purchase
Common Stock 20,000 N/A N/A
Purchase
Common Stock 10,300 N/A N/A
Purchase
Common Stock 1,000 N/A N/A
Purchase
Common Stock 5,000 N/A N/A
Purchase
Common Stock 5,000 N/A N/A
Purchase
Common Stock 2,500 N/A N/A
Purchase
Common Stock 3,000 N/A N/A
Purchase
Common Stock 2,213 N/A N/A
Sale
Common Stock 25,000 N/A N/A

Plus Therapeutics key executives

Plus Therapeutics, Inc. executives and other stock owners filed with the SEC: